Vepdegestrant and Sertraline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordVepdegestrant
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of your medicines can affect the timing of your heartbeat. Sertraline (an antidepressant) and vepdegestrant (a cancer medicine) can each slightly stretch out a part of the heart's electrical cycle called the QT interval. When two medicines that do this are taken together, that effect can add up and, in rare cases, lead to a dangerous irregular heartbeat.
This concern is based mostly on theory, not on lots of real-world reports, so try not to panic. Please do not stop either medicine on your own. Your care team can manage this safely, often with heart tracings (ECGs) and by keeping an eye on things. Bring up any dizziness, fainting, or fluttering heartbeat right away.
Mechanism: Additive QTc prolongation. Both sertraline (modest QT effect) and vepdegestrant carry QT-prolonging potential; neither is a prodrug relevant here, so the concern is pharmacodynamic, not activation-based.
Direction/magnitude: Increased QTc and torsade de pointes risk; magnitude unquantified. Evidence: theoretical. Onset: unspecified.
- Avoid concurrent use where possible; consider a non-QT-prolonging antidepressant.
- If unavoidable, obtain baseline and on-treatment ECGs; correct hypokalemia/hypomagnesemia.
- QTc >480 ms or >60 ms rise (500 ms: withhold; resume reduced if no reversible cause; discontinue if recurs or if TdP/serious arrhythmia develops.
What happens
An increased risk of QT interval prolongation and an increased risk of torsade de pointes, polymorphic ventricular tachycardia, other serious arrhythmia symptoms
Interaction Deep Dive
Do not co-administer vepdegestrant with other agents recognized as capable of prolonging the QTc interval, since doing so could cause a larger QTc prolongation along with adverse reactions linked to QTc prolongation, such as torsade de pointes, additional serious arrhythmias, and sudden death. When such combined use is unavoidable, perform ECGs at the start of and throughout the concomitant use, as well as whenever clinically warranted. For patients whose QTc exceeds 480 ms or rises by more than 60 ms from baseline (while remaining less than or equal to 500 ms): hold vepdegestrant until the QTc falls to 480 ms or lower and is no more than 60 ms above baseline. Correct any reversible causes (for example, hypokalemia, hypomagnesemia) and then restart vepdegestrant at the same dose. Begin ECG monitoring at more frequent intervals. For patients whose QTc exceeds 500 ms: hold vepdegestrant until the QTc is 480 ms or lower and less than 60 ms above baseline. Should a reversible cause be found and corrected, resume vepdegestrant at the same dose. Should no reversible cause be found, resume vepdegestrant at a lowered dose. Monitor ECGs more frequently, and permanently stop vepdegestrant should QTc greater than 500 ms occur again. For patients who develop torsade de pointes, polymorphic ventricular tachycardia, or symptoms of serious arrhythmia: permanently discontinue vepdegestrant1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
The most important thing: keep taking both medicines exactly as prescribed unless your care team tells you otherwise. This interaction can be managed.
Here is what your team typically does:
- They may prefer to avoid combining these two and could consider a different antidepressant if suitable.
- If both are needed, they will check ECGs before and during treatment.
- They will keep your potassium and magnesium in a healthy range, since low levels raise the risk.
- The vepdegestrant dose may be paused or adjusted and individualized based on your ECG results.
Tell your pharmacist or doctor about fainting, palpitations, or dizziness right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Vepdegestrant and Sertraline together?
Taking sertraline with vepdegestrant may add together to prolong the QT interval and raise the risk of a serious irregular heartbeat, so your care team will usually avoid the combo or monitor your ECG and electrolytes closely. Do not stop either drug on your own; report any fainting or palpitations promptly. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Vepdegestrant and Sertraline interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Vepdegestrant and Sertraline interaction managed?
The most important thing: keep taking both medicines exactly as prescribed unless your care team tells you otherwise. This interaction can be managed. Here is what your team typically does: They may prefer to avoid combining these two and could consider a different antidepressant if suitable. If both are needed, they will check ECGs before and during treatment. They will keep your potassium and ma… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Vepdegestrant or Sertraline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: VEPPANU oral tablet, vepdegestrant oral tablet. Pfizer Inc. New York, NY, 2026. DailyMed
Keep reading about Sertraline
Keep reading about Vepdegestrant
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist